tiprankstipranks
CymaBay Therapeutics Revamps Executive Compensation Agreements
Company Announcements

CymaBay Therapeutics Revamps Executive Compensation Agreements

Don't Miss our Black Friday Offers:

The latest announcement is out from CymaBay Therapeutics (CBAY).

CymaBay Therapeutics, Inc. has made significant changes to its executive officers’ employment agreements, removing certain clauses related to severance payments and introducing provisions for a tax make-whole payment. This move aims to address potential excise taxes on executive compensation, ensuring that their executives are not financially penalized for these taxes under the updated tax laws.

Learn more about CBAY stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCymaBay Therapeutics: Major Acquisition and Leadership Overhaul
TheFlyGilead completes acquisition of CymaBay
TheFlyGilead says CymaBay deal to lower 2024 EPS by $3.35-$3.45
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App